⚡ Quick Summary

This study developed ensemble learning-based physiological age (PA) models to evaluate drug metabolism using data from 22,307 NHANES participants. The findings indicate that physiological age is significantly associated with Phase I drug-metabolizing enzyme phenotypes, providing a new perspective on drug kinetics and health status.

🔍 Key Details

• 📊 Dataset: 22,307 NHANES participants (51.5% female, mean age 46.0 years)
• 🧩 Features used: Body composition, blood and urine biomarkers, disease variables
• ⚙️ Technology: Ensemble learning models (PA-M1 and PA-M2)
• 🏆 Performance: Models validated independently with satisfactory results

🔑 Key Takeaways

• 📊 Physiological age (PA) models provide robust assessments from easily obtained biomarkers.
• 💡 Klotho, lean body mass, glycohemoglobin, and systolic blood pressure were top predictors for PA-M1.
• 👩‍🔬 Glycohemoglobin, serum creatinine, total cholesterol, and urine creatinine were top predictors for PA-M2.
• 🏆 No evidence of algorithmic bias based on sex or race/ethnicity was found.
• 🌍 Study highlights the importance of physiological age in drug metabolism.
• 🔬 Telomere attrition was associated with greater PA in both models.
• 🤖 Ensemble learning offers a promising approach for assessing health status and drug kinetics.

📚 Background

Understanding the relationship between age and health is crucial in pharmacology and medicine. Age is a significant predictor of health status, disease progression, and drug metabolism. Traditional methods of assessing physiological age often lack precision and can be influenced by various factors. The advent of artificial intelligence and machine learning provides an opportunity to refine these assessments, potentially leading to better healthcare outcomes.

🗒️ Study

The study aimed to develop two ensemble learning-based models for physiological age (PA) using data from the National Health and Nutrition Examination Survey (NHANES). The researchers created PA-M1, which included a variety of predictors such as body composition and disease variables, and PA-M2, which focused on blood and urine-derived variables. The study assessed the activity of several drug-metabolizing enzymes and telomere attrition in relation to the predicted physiological age.

📈 Results

The results demonstrated that both PA-M1 and PA-M2 showed greater dispersion across age strata, with a right skew for younger participants and a left skew for older participants. The models performed well in independent validation, indicating their reliability. Notably, physiological age was found to be associated with the activity of several key enzymes, including CYP2E1, CYP1A2, CYP2A6, xanthine oxidase (XO), and N-acetyltransferase-2 (NAT-2). Additionally, telomere attrition correlated with increased physiological age in both models.

🌍 Impact and Implications

The implications of this study are significant for the fields of pharmacology and personalized medicine. By utilizing easily obtainable blood and urine biomarkers, healthcare professionals can gain a more accurate understanding of a patient’s physiological age, which can inform drug dosing and treatment plans. This research opens the door for further exploration into how physiological age can impact drug metabolism and overall health, potentially leading to more tailored therapeutic approaches.

🔮 Conclusion

This study highlights the potential of ensemble learning models in assessing physiological age and its relationship with drug metabolism. The findings suggest that physiological age is a valuable metric that can enhance our understanding of health status and inform clinical decisions. As we continue to integrate artificial intelligence into healthcare, the future looks promising for improving patient outcomes through more personalized approaches.

💬 Your comments

What are your thoughts on the use of physiological age in drug metabolism? We would love to hear your insights! 💬 Leave your comments below or connect with us on social media:

• 🐦 X
• 📘 Facebook
• 🔗 LinkedIn